A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
Adult
Aged
Biomarkers, Tumor
/ blood
Brain Neoplasms
/ blood
Case-Control Studies
Cell-Derived Microparticles
/ metabolism
Cohort Studies
Extracellular Vesicles
/ metabolism
Female
Glioma
/ blood
Humans
Liquid Biopsy
/ methods
Male
Middle Aged
Proteomics
/ methods
Tandem Mass Spectrometry
/ methods
Workflow
DIA
SWATH
extracellular vesicle
glioblastoma
glioma
liquid biospsy
mass spectrometry
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
03 Jul 2020
03 Jul 2020
Historique:
received:
26
05
2020
revised:
01
07
2020
accepted:
01
07
2020
entrez:
9
7
2020
pubmed:
9
7
2020
medline:
26
2
2021
Statut:
epublish
Résumé
Improving outcomes for diffuse glioma patients requires methods that can accurately and sensitively monitor tumour activity and treatment response. Extracellular vesicles (EV) are membranous nanoparticles that can traverse the blood-brain-barrier, carrying oncogenic molecules into the circulation. Measuring clinically relevant glioma biomarkers cargoed in circulating EVs could revolutionise how glioma patients are managed. Despite their suitability for biomarker discovery, the co-isolation of highly abundant complex blood proteins has hindered comprehensive proteomic studies of circulating-EVs. Plasma-EVs isolated from pre-operative glioma grade II-IV patients (
Identifiants
pubmed: 32635403
pii: ijms21134754
doi: 10.3390/ijms21134754
pmc: PMC7369771
pii:
doi:
Substances chimiques
Biomarkers, Tumor
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Biochem Biophys Res Commun. 1997 Feb 13;231(2):509-13
pubmed: 9070310
PLoS One. 2017 Nov 7;12(11):e0187246
pubmed: 29112949
Mol Cell Proteomics. 2011 Jan;10(1):M110.000570
pubmed: 20852191
Mol Cell Proteomics. 2015 May;14(5):1361-72
pubmed: 25755296
Contrast Media Mol Imaging. 2018 Dec 2;2018:6828396
pubmed: 30627060
Int J Mol Sci. 2015 Nov 06;16(11):26706-20
pubmed: 26561808
J Extracell Vesicles. 2018 Dec 28;8(1):1560809
pubmed: 30651940
Nat Struct Mol Biol. 2008 Dec;15(12):1255-62
pubmed: 19011634
Int J Cancer. 2013 Jan 1;132(1):116-27
pubmed: 22674182
Cell Death Dis. 2013 Oct 31;4:e888
pubmed: 24176846
Mol Cell Proteomics. 2002 Nov;1(11):845-67
pubmed: 12488461
Mol Cell. 2006 Sep 15;23(6):887-97
pubmed: 16973440
Curr Oncol Rep. 2010 Jan;12(1):26-33
pubmed: 20425605
Oncotarget. 2016 Mar 22;7(12):14161-71
pubmed: 26895104
Nat Protoc. 2015 Mar;10(3):426-41
pubmed: 25675208
Cell Stress Chaperones. 2019 Jan;24(1):17-27
pubmed: 30506376
Brain Tumor Pathol. 2019 Apr;36(2):29-39
pubmed: 30859343
Anal Bioanal Chem. 2008 May;391(1):151-9
pubmed: 18264818
Clin Radiol. 2015 Nov;70(11):1299-312
pubmed: 26272530
J Proteome Res. 2015 Jun 5;14(6):2367-84
pubmed: 25927954
J Exp Clin Cancer Res. 2010 Jul 19;29:97
pubmed: 20637127
Clin Cancer Res. 2013 Feb 15;19(4):764-72
pubmed: 23209033
Neuropathology. 2011 Feb;31(1):29-37
pubmed: 20497343
Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150
pubmed: 28815663
Oncotarget. 2015 Oct 6;6(30):30232-8
pubmed: 26338964
PLoS One. 2007 Dec 12;2(12):e1297
pubmed: 18074021
Proteomics. 2019 Apr;19(8):e1800161
pubmed: 30790448
Clin Neuroradiol. 2018 Sep;28(3):401-411
pubmed: 28466127
Expert Rev Proteomics. 2015 Aug;12(4):329-31
pubmed: 26186709
Mol Neurobiol. 2019 Jun;56(6):4566-4581
pubmed: 30353492
Neurol Sci. 2003 Oct;24(3):159-60
pubmed: 14598065
Am J Pathol. 2003 Nov;163(5):1949-60
pubmed: 14578194
PLoS One. 2015 May 07;10(5):e0125791
pubmed: 25950799
J Proteome Res. 2018 Oct 5;17(10):3599-3605
pubmed: 30192545
PLoS One. 2011 Mar 21;6(3):e18074
pubmed: 21445310
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12115-20
pubmed: 19581582
Proteomics. 2012 Apr;12(8):1111-21
pubmed: 22577012
BMC Cancer. 2014 Dec 16;14:962
pubmed: 25510783
Proc Natl Acad Sci U S A. 2017 Oct 24;114(43):E9086-E9095
pubmed: 29073105
Proteomics. 2019 Jan;19(1-2):e1800157
pubmed: 30451371
J Neuroimmunol. 2015 Jan 15;278:271-6
pubmed: 25468776
PLoS One. 2018 Mar 7;13(3):e0193799
pubmed: 29513714
Mol Cell Proteomics. 2012 Jun;11(6):O111.016717
pubmed: 22261725
EBioMedicine. 2018 Nov;37:78-90
pubmed: 30385233
Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4009-14
pubmed: 23412337
Anal Bioanal Chem. 2018 Jun;410(16):3805-3814
pubmed: 29671027
FASEB J. 2009 May;23(5):1541-57
pubmed: 19109410
Hum Mol Genet. 2003 Aug 1;12(15):1917-25
pubmed: 12874111
J Proteome Res. 2014 Dec 5;13(12):5415-30
pubmed: 25244318
Acta Neuropathol. 2015 Jun;129(6):849-65
pubmed: 25720744
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
Mol Cancer. 2011 Jul 13;10:83
pubmed: 21752281
Prostate. 2012 Feb;72(3):253-69
pubmed: 21630292
Arch Pathol Lab Med. 2018 Jul;142(7):804-814
pubmed: 29775073
J Extracell Vesicles. 2018 Jun 04;7(1):1481321
pubmed: 29887978
Mol Cell Proteomics. 2018 Oct;17(10):1948-1964
pubmed: 30006486
Science. 2017 Aug 18;357(6352):
pubmed: 28818916
J Invest Dermatol. 2020 Jan;140(1):212-222.e11
pubmed: 31254517
Breast Cancer Res Treat. 2008 Nov;112(2):229-36
pubmed: 18095154
Nanomedicine. 2011 Dec;7(6):780-8
pubmed: 21601655
J Med Genet. 2006 May;43(5):441-3
pubmed: 16399879
J Neurooncol. 2017 Jan;131(2):233-244
pubmed: 27770278
AJNR Am J Neuroradiol. 2011 Dec;32(11):1978-85
pubmed: 21393407
Platelets. 2017 May;28(3):214-221
pubmed: 28102737
NPJ Precis Oncol. 2018 Dec 12;2:28
pubmed: 30564636
Oncol Lett. 2019 Nov;18(5):4691-4702
pubmed: 31611978
Nat Methods. 2013 Dec;10(12):1246-53
pubmed: 24162925
Genes Chromosomes Cancer. 2005 Dec;44(4):351-64
pubmed: 16080200
J Neurosurg. 2017 Aug;127(2):388-396
pubmed: 27885954
J Biol Chem. 2013 Jun 14;288(24):17734-44
pubmed: 23612981
Nat Commun. 2018 Jan 12;9(1):175
pubmed: 29330365
J Cell Biol. 2018 Aug 6;217(8):2877-2890
pubmed: 29930202
Proteomes. 2017 Jul 07;5(3):
pubmed: 28686225
Clin Neurol Neurosurg. 2016 Jan;140:6-10
pubmed: 26615463
Cell Death Dis. 2018 Aug 29;9(9):865
pubmed: 30158634
Nat Commun. 2011 Feb 01;2:180
pubmed: 21285958
Cancer Res. 2006 Apr 15;66(8):3987-91
pubmed: 16618716
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Pharmgenomics Pers Med. 2014 Feb 13;7:65-77
pubmed: 24634586
PLoS Biol. 2014 Apr 22;12(4):e1001844
pubmed: 24756126
Biochim Biophys Acta. 2007 Jan;1774(1):93-101
pubmed: 17085086
Clin Cancer Res. 2009 Nov 15;15(22):6830-40
pubmed: 19861441
Front Genet. 2014 Dec 05;5:426
pubmed: 25538733
J Pathol. 2019 Sep;249(1):26-38
pubmed: 30953361
Neurotherapeutics. 2017 Apr;14(2):307-320
pubmed: 28108885
J Neurooncol. 2017 Sep;134(2):433-441
pubmed: 28674974
Oncol Lett. 2016 Oct;12(4):2524-2530
pubmed: 27698822
Nat Methods. 2011 May;8(5):430-5
pubmed: 21423193
Mol Cell. 2013 Jun 27;50(6):805-17
pubmed: 23747015
Exp Cell Res. 2015 Mar 15;332(2):223-35
pubmed: 25704758
Neoplasia. 2004 Jan-Feb;6(1):1-6
pubmed: 15068665
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Sci Rep. 2016 Nov 08;6:36338
pubmed: 27821849
Eur J Cancer. 2003 Jan;39(2):184-91
pubmed: 12509950
J Clin Oncol. 2014 Aug 1;32(22):e80-4
pubmed: 24567434
Cancer Med. 2017 Dec;6(12):2858-2866
pubmed: 29105360
Methods Mol Biol. 2015;1295:167-77
pubmed: 25820722
Expert Rev Mol Diagn. 2014 Sep;14(7):819-25
pubmed: 25136839
Structure. 2012 May 9;20(5):814-25
pubmed: 22503819
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
J Neuropathol Exp Neurol. 2015 May;74(5):425-41
pubmed: 25853691
Immun Inflamm Dis. 2015 Sep;3(3):133-40
pubmed: 26417432
Neuro Oncol. 2017 Oct 19;19(11):1494-1502
pubmed: 28453784
Radiographics. 2007 Mar-Apr;27(2):525-51
pubmed: 17374867